Answers are grounded in this paper and cite their sources.
Prospective multicentre study shows effective focal therapy for localised prostate cancer, suggesting safety and efficacy.
Targeted microwave ablation using OBT Fusion technology appears to be a safe and effective focal therapy procedure for localised intermediate-risk PCa. The VIOLETTE trial achieved its primary endpoint, with 81% patients free of in-field csPCa at 12 months.
No takes yet. Share an insight, caveat, or question.
Delongchamps et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: